{"transactions":[{"id":673590,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T20:30:12.000Z","date":"2026-08-26","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":1.72,"value":34400.0,"ownership":{"direct":true},"balance_after":132500,"source":{"system":"sec-edgar","filing":"0001104659-26-102467","document":"tm2624205-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465926102467/tm2624205-1_4seq1.xml","form_type":"4"}},{"id":717344,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-03T01:57:34.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. (\"Company\") common stock, par value $0.001 per share (\"Common Stock\"). The RSUs were issued under the Company's 2025 Equity Incentive Plan for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest on June 15, 2027. Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock no later than the fifteenth (15th) day of the third (3rd) calendar month following the calendar year in which the date of grant occurs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on June 15, 2027. Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock no later than the fifteenth (15th) day of the third (3rd) calendar month following the calendar year in which the date of grant occurs."}],"balance_after":100000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-26-080495","document":"tm2619727-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465926080495/tm2619727-5_4seq1.xml","form_type":"4"}},{"id":837116,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-17T22:06:15.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":104500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"104,500 Restricted Stock Units (\"RSUs\") previously granted by Cypherpunk Technologies Inc. (the \"Company\") to the reporting person on December 23, 2025 pursuant to the Company's 2025 Equity Incentive Plan for no consideration (the \"December 2025 RSUs\") were settled on March 13, 2026 on a 1 for 1 basis for shares of the Company's common stock, par value $0.001 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The December 2025 RSUs vested at issuance on their grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The December 2025 RSUs vested at issuance on their grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":104500},"source":{"system":"sec-edgar","filing":"0001104659-26-029646","document":"tm269084-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465926029646/tm269084-10_4seq1.xml","form_type":"4"}},{"id":837115,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T22:06:15.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":104500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"104,500 Restricted Stock Units (\"RSUs\") previously granted by Cypherpunk Technologies Inc. (the \"Company\") to the reporting person on December 23, 2025 pursuant to the Company's 2025 Equity Incentive Plan for no consideration (the \"December 2025 RSUs\") were settled on March 13, 2026 on a 1 for 1 basis for shares of the Company's common stock, par value $0.001 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"104,500 Restricted Stock Units (\"RSUs\") previously granted by Cypherpunk Technologies Inc. (the \"Company\") to the reporting person on December 23, 2025 pursuant to the Company's 2025 Equity Incentive Plan for no consideration (the \"December 2025 RSUs\") were settled on March 13, 2026 on a 1 for 1 basis for shares of the Company's common stock, par value $0.001 per share."}],"balance_after":152500,"source":{"system":"sec-edgar","filing":"0001104659-26-029646","document":"tm269084-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465926029646/tm269084-10_4seq1.xml","form_type":"4"}},{"id":957026,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-12-30T21:33:19.000Z","date":"2025-12-23","kind":"grant","planned":false,"acquired":true,"shares":104500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents RSUs to be settled on a 1 for 1 basis for shares of Company Common Stock.  The RSUs (the \"December 2025 RSUs\") were awarded pursuant to the Company's 2025 Equity Incentive Plan for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The December 2025 RSUs vested at issuance on December 23, 2025 (the \"Grant Date\").  Subject to the terms of the December 2025 RSU award and applicable tax withholdings, the Company shall settle the December 2025 RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The December 2025 RSUs vested at issuance on December 23, 2025 (the \"Grant Date\").  Subject to the terms of the December 2025 RSU award and applicable tax withholdings, the Company shall settle the December 2025 RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date."}],"balance_after":104500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":104500},"source":{"system":"sec-edgar","filing":"0001104659-25-125256","document":"tm2534450-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465925125256/tm2534450-5_4seq1.xml","form_type":"4"}},{"id":957025,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-12-30T21:33:19.000Z","date":"2025-12-26","kind":"exercise","planned":false,"acquired":true,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents RSUs to be settled on a 1 for 1 basis for shares of Company Common Stock.  The November 2025 RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration."},{"field":"kind","element":"transactionCoding","label":"F1","text":"83,000 Restricted Stock Units (\"RSUs\") previously granted by Cypherpunk Technologies Inc. (the \"Company\") to the reporting person on November 11, 2025 (the \"November 2025 RSUs\") were settled on December 26, 2025 on a net issue basis such that, of the 83,000 shares of the Company's common stock, par value $0.001 per share (\"Common Stock\") underlying the November 2025 RSUs, the Company issued to the reporting person on such settlement date only 48,000 of such shares, and the Company withheld on such settlement date the remaining 35,000 of such shares in order to satisfy tax withholding obligations in connection with the settlement of the November 2025 RSUs. None of such 35,000 shares of Common Stock so withheld by the Company constituted sales of such shares by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The November 2025 RSUs vested at issuance on their grant date.  On December 26, 2025, the Compensation Committee of the Board of Directors took action to permit the early settlement of the November 2025 RSUs on a net issue basis as further described in footnote (1) above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The November 2025 RSUs vested at issuance on their grant date.  On December 26, 2025, the Compensation Committee of the Board of Directors took action to permit the early settlement of the November 2025 RSUs on a net issue basis as further described in footnote (1) above."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0001104659-25-125256","document":"tm2534450-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465925125256/tm2534450-5_4seq1.xml","form_type":"4"}},{"id":957024,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-30T21:33:19.000Z","date":"2025-12-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":35000,"price":1.2,"value":42000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"83,000 Restricted Stock Units (\"RSUs\") previously granted by Cypherpunk Technologies Inc. (the \"Company\") to the reporting person on November 11, 2025 (the \"November 2025 RSUs\") were settled on December 26, 2025 on a net issue basis such that, of the 83,000 shares of the Company's common stock, par value $0.001 per share (\"Common Stock\") underlying the November 2025 RSUs, the Company issued to the reporting person on such settlement date only 48,000 of such shares, and the Company withheld on such settlement date the remaining 35,000 of such shares in order to satisfy tax withholding obligations in connection with the settlement of the November 2025 RSUs. None of such 35,000 shares of Common Stock so withheld by the Company constituted sales of such shares by the reporting person."}],"balance_after":48000,"source":{"system":"sec-edgar","filing":"0001104659-25-125256","document":"tm2534450-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465925125256/tm2534450-5_4seq1.xml","form_type":"4"}},{"id":957023,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-30T21:33:19.000Z","date":"2025-12-26","kind":"exercise","planned":false,"acquired":true,"shares":83000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"83,000 Restricted Stock Units (\"RSUs\") previously granted by Cypherpunk Technologies Inc. (the \"Company\") to the reporting person on November 11, 2025 (the \"November 2025 RSUs\") were settled on December 26, 2025 on a net issue basis such that, of the 83,000 shares of the Company's common stock, par value $0.001 per share (\"Common Stock\") underlying the November 2025 RSUs, the Company issued to the reporting person on such settlement date only 48,000 of such shares, and the Company withheld on such settlement date the remaining 35,000 of such shares in order to satisfy tax withholding obligations in connection with the settlement of the November 2025 RSUs. None of such 35,000 shares of Common Stock so withheld by the Company constituted sales of such shares by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents RSUs to be settled on a 1 for 1 basis for shares of Company Common Stock.  The November 2025 RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration."}],"balance_after":83000,"source":{"system":"sec-edgar","filing":"0001104659-25-125256","document":"tm2534450-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465925125256/tm2534450-5_4seq1.xml","form_type":"4"}},{"id":999934,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-11-13T21:54:12.000Z","date":"2025-11-11","kind":"grant","planned":false,"acquired":true,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (\"RSUs\") to be settled on a 1 for 1 basis for shares of Cypherpunk Technologies Inc. (\"Company\") common stock, par value $0.001 per share (\"Common Stock\").  The RSUs were awarded pursuant to the Company's 2022 Equity Incentive Plan for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested at issuance on November 11, 2025 (the \"Grant Date\").  Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested at issuance on November 11, 2025 (the \"Grant Date\").  Subject to the terms of the RSU award and applicable tax withholdings, the Company shall settle the RSUs for Common Stock as soon as practicable following the earlier to occur of (i) the fifth (5th) business day after the date the reporting person ceases for any reason to be a member of the Company's Board of Directors or (ii) the date of the first annual meeting of stockholders of the Company that occurs following the Grant Date."}],"balance_after":83000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0001104659-25-111433","document":"tm2531210-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465925111433/tm2531210-3_4seq1.xml","form_type":"4"}},{"id":1390655,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-04T21:24:00.000Z","date":"2024-10-02","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of December 31, 2024, March 31, 2025, June 30, 2025, and September 30, 2025 for so long as the reporting person continues to be a director, consultant or service provider of the Company."}],"balance_after":30000,"derivative":{"exercise_price":2.45,"expiration_date":"2034-10-02","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-24-106333","document":"tm2425653-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465924106333/tm2425653-3_4seq1.xml","form_type":"4"}},{"id":1664897,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-01T02:36:12.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company."}],"balance_after":30000,"derivative":{"exercise_price":2.68,"expiration_date":"2034-01-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-24-009030","document":"tm244775-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465924009030/tm244775-8_4seq1.xml","form_type":"4"}},{"id":1775637,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-09-21T13:13:32.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":24.07,"expiration_date":"2025-02-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-23-019349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019349/doc4.xml","form_type":"4"}},{"id":1775636,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-09-21T13:13:32.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":14.05,"expiration_date":"2026-02-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-23-019349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019349/doc4.xml","form_type":"4"}},{"id":1775635,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-09-21T13:13:32.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":15.1,"expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-23-019349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019349/doc4.xml","form_type":"4"}},{"id":1775634,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-09-21T13:13:32.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":14.15,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-23-019349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019349/doc4.xml","form_type":"4"}},{"id":1775633,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-09-21T13:13:32.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":7.23,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-23-019349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019349/doc4.xml","form_type":"4"}},{"id":1775632,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-09-21T13:13:32.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":3.51,"expiration_date":"2030-02-19","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000899243-23-019349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019349/doc4.xml","form_type":"4"}},{"id":1775631,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-09-21T13:13:32.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Company Common Stock granted under an Issuer equity plan (each, a \"Company Stock Option\") that was then outstanding that has an exercise price per share of Company Common Stock that is greater than $3.00 was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":7.61,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000899243-23-019349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019349/doc4.xml","form_type":"4"}},{"id":1775630,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-21T13:13:32.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award covering shares of Company Common Stock that is subject to vesting conditions based solely on continued employment or service granted under an Issuer equity plan (each, a \"Company RSU\") and each performance stock unit award covering shares of Company Common Stock that are subject to performance-based vesting conditions granted under an Issuer equity plan (each, a \"Company PSU\") (the Company RSUs and the Company PSUs, collectively \"Company Equity Awards\") that was then outstanding was cancelled, and the holder of such cancelled Company Equity Award is entitled, in exchange therefor, to receive (without interest and less applicable tax withholdings) (i) an amount in cash equal to the product of (A) the total number of shares of Company Common Stock subject to (or deliverable under) such Company Equity Award immediately prior to the Effective Time multiplied by (B) the Cash Consideration,"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"(Continued from Footnote 4) and (ii) a CVR Payment for each share of Company Common Stock subject thereto (the \"Equity Award Consideration\"), provided, that any payment of the Equity Award Consideration in respect of an unvested Company Equity Award will remain subject to the same vesting conditions as were applicable to such Company Equity Award immediately prior to the Effective Time and shall only become payable to the holder of such cancelled Company Equity Award to the extent such vesting conditions are satisfied following the closing of the Merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-019349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019349/doc4.xml","form_type":"4"}},{"id":1775629,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-21T13:13:32.000Z","date":"2023-09-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":49250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 6, 2023, by and among the Issuer, Resistance Acquisition, Inc. (\"Parent\"), and Resistance Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub merged with and into Issuer with the Issuer being the surviving corporation (the \"Merger\"). Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each issued and outstanding share of common stock of the Issuer (\"Company Common Stock\") was cancelled and retired and automatically converted into the right to receive (x) $2.15, payable to the holder thereof in cash,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) without interest (the \"Cash Consideration\") but subject to reduction for any applicable withholding taxes payable in respect thereof and (y) one (1) contractual contingent value right  (a \"CVR Payment\") that represents the right to receive $0.85 upon satisfaction of certain conditions set forth in a Contingent Value Rights Agreement, dated September 21, 2023, by and between Parent and Equiniti Trust Company, LLC."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Due to administrative error, the Reporting Person's previous Form 4 filings over-reported the securities beneficially owned by the Reporting Person by 750 shares of common stock of the Issuer. This filing corrects such error and lists the correct amount of securities beneficially owned directly by the Reporting Person."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-23-019349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000089924323019349/doc4.xml","form_type":"4"}},{"id":1796076,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-25T20:31:29.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company."}],"balance_after":17500,"derivative":{"exercise_price":2.21,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001104659-23-095361","document":"tm2324823-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465923095361/tm2324823-7_4seq1.xml","form_type":"4"}},{"id":1927027,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-05T00:12:57.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested."}],"balance_after":175000,"derivative":{"exercise_price":0.34,"expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001104659-23-041747","document":"tm2311741-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465923041747/tm2311741-6_4seq1.xml","form_type":"4"}},{"id":1972641,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-03T20:49:50.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 12 months measured from March 1, 2023, subject to Reporting Person's continuous service status as of each such date."}],"balance_after":40000,"derivative":{"exercise_price":1.705,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001140361-23-010157","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036123010157/form4.xml","form_type":"4"}},{"id":2025000,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:07:51.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 8, 2023, subject to the Reporting Person's continued service with the Issuer through the vesting date."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0000904454-23-000101","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445423000101/edgar.xml","form_type":"4"}},{"id":2046333,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-25T20:54:15.000Z","date":"2023-01-23","kind":"purchase","acquired":true,"shares":50000,"price":1.4316,"value":71580.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.395 to $1.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by the Dietz Family Trust, for which the reporting person and his spouse serve as co-trustees."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001567619-23-001284","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000156761923001284/doc1.xml","form_type":"4"}},{"id":2076073,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-27T17:31:40.000Z","date":"2022-12-22","kind":"sale","acquired":false,"shares":22500,"price":1.169,"value":26302.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.1628 to $1.175, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."}],"balance_after":21000,"source":{"system":"sec-edgar","filing":"0001140361-22-047071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036122047071/form4.xml","form_type":"4"}},{"id":2167173,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-03T01:24:01.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of September 1, 2022, the Vesting Start Date."}],"balance_after":30000,"derivative":{"exercise_price":1.43,"expiration_date":"2032-08-31","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-22-097616","document":"tm2225099-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465922097616/tm2225099-5_4seq1.xml","form_type":"4"}},{"id":2337390,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-11T21:06:26.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal monthly installments over 12 months measured from March 11, 2022 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":24000,"derivative":{"exercise_price":5.1,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001140361-22-009257","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036122009257/form4.xml","form_type":"4"}},{"id":2337389,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-11T21:06:26.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 11, 2022."}],"balance_after":43500,"source":{"system":"sec-edgar","filing":"0001140361-22-009257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036122009257/form4.xml","form_type":"4"}},{"id":2385782,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-18T17:14:10.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 16, 2022, subject to the Reporting Person's continued service with the Issuer through the vesting date."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0000904454-22-000163","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445422000163/edgar.xml","form_type":"4"}},{"id":2415938,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T02:48:12.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of January 1, 2022, the Vesting Start Date."}],"balance_after":60000,"derivative":{"exercise_price":1.94,"expiration_date":"2032-01-30","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-22-011051","document":"tm225302-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465922011051/tm225302-8_4seq1.xml","form_type":"4"}},{"id":2751143,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T18:10:08.000Z","date":"2021-04-09","kind":"purchase","acquired":true,"shares":1000,"price":8.5,"value":8500.0,"ownership":{"direct":true},"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001209191-21-026382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919121026382/doc4.xml","form_type":"4"}},{"id":2751142,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T18:10:08.000Z","date":"2021-04-09","kind":"purchase","acquired":true,"shares":1500,"price":8.48,"value":12720.0,"ownership":{"direct":true},"balance_after":36500,"source":{"system":"sec-edgar","filing":"0001209191-21-026382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919121026382/doc4.xml","form_type":"4"}},{"id":2789033,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-15T19:25:29.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal monthly installments over 12 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":9.99,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-020577","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919121020577/doc4.xml","form_type":"4"}},{"id":2789032,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T19:25:29.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 12, 2021."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001209191-21-020577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919121020577/doc4.xml","form_type":"4"}},{"id":2843536,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-22T18:27:53.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price is equal to the closing sales price per share of the Issuer's common stock as reported on The Nasdaq Global Market on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest as to 1/12 of the shares subject to the stock option on the one-month anniversary following February 18, 2021, and on the same calendar date of each successive month thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":7000,"derivative":{"exercise_price":7.61,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000904454-21-000228","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445421000228/edgar.xml","form_type":"4"}},{"id":2843535,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-22T18:27:53.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 18, 2021, subject to the Reporting Person's continued service with the Issuer through the vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0000904454-21-000228","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445421000228/edgar.xml","form_type":"4"}},{"id":2914790,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-07T00:12:50.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":37300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of January 1, 2021, the Vesting Start Date."}],"balance_after":37300,"derivative":{"exercise_price":2.18,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":37300},"source":{"system":"sec-edgar","filing":"0001104659-21-001649","document":"tm211724d4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465921001649/tm211724d4_4seq1.xml","form_type":"4"}},{"id":3059874,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-13T01:17:35.000Z","date":"2020-08-10","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three month anniversary of August 10, 2020, the Vesting Start Date."}],"balance_after":12500,"derivative":{"exercise_price":1.97,"expiration_date":"2030-08-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-20-094194","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465920094194/a4.xml","form_type":"4"}},{"id":3177717,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-14T00:21:59.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of April 9, 2020, the Vesting Start Date."}],"balance_after":12500,"derivative":{"exercise_price":1.69,"expiration_date":"2030-04-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-20-046078","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465920046078/a4.xml","form_type":"4"}},{"id":3204865,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-17T17:17:24.000Z","date":"2020-03-16","kind":"purchase","acquired":true,"shares":1000,"price":4.95,"value":4950.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-20-019685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919120019685/doc4.xml","form_type":"4"}},{"id":3210793,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-13T17:22:03.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal monthly installments over 12 months measured from March 12, 2020 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":5.6,"expiration_date":"2030-03-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-018977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919120018977/doc4.xml","form_type":"4"}},{"id":3210792,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-13T17:22:03.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 12, 2020."}],"balance_after":29000,"source":{"system":"sec-edgar","filing":"0001209191-20-018977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919120018977/doc4.xml","form_type":"4"}},{"id":3226640,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-04T22:07:33.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of January 1, 2020, the Vesting Start Date."}],"balance_after":25000,"derivative":{"exercise_price":2.94,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-029236","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465920029236/a4.xml","form_type":"4"}},{"id":3256793,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-21T21:31:03.000Z","date":"2020-02-19","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price is equal to the closing sales price per share of the Issuer's common stock as reported on The Nasdaq Global Market on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest as to 1/12 of the shares subject to the stock option on the one-month anniversary following February 19, 2020, and on the same calendar date of each successive month thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":7000,"derivative":{"exercise_price":3.51,"expiration_date":"2030-02-19","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000904454-20-000238","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445420000238/edgar.xml","form_type":"4"}},{"id":3256792,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-21T21:31:03.000Z","date":"2020-02-19","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 19, 2020, subject to the Reporting Person's continued service with the Issuer through the vesting date."}],"balance_after":21000,"source":{"system":"sec-edgar","filing":"0000904454-20-000238","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445420000238/edgar.xml","form_type":"4"}},{"id":3312510,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-13T08:17:19.000Z","date":"2020-01-10","kind":"purchase","acquired":true,"shares":4000,"price":13.94,"value":55760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.89 to $13.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."}],"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001209191-20-003153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919120003153/doc4.xml","form_type":"4"}},{"id":3492366,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-12T20:43:16.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of June 11, 2019, the Vesting Start Date."}],"balance_after":15000,"derivative":{"exercise_price":1.39,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-19-035074","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465919035074/a4.xml","form_type":"4"}},{"id":3551040,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-23T18:53:27.000Z","date":"2019-04-23","kind":"purchase","acquired":true,"shares":5000,"price":11.099,"value":55495.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.085 to $11.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-19-025623","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919119025623/doc4.xml","form_type":"4"}},{"id":3551391,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-22T21:34:05.000Z","date":"2019-04-22","kind":"purchase","acquired":true,"shares":5000,"price":11.05,"value":55250.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-19-025563","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919119025563/doc4.xml","form_type":"4"}},{"id":3579609,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option ( Right to Buy)","published_at":"2019-03-25T21:53:44.000Z","date":"2019-03-21","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 12 months measured from March 21, 2019 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":20000,"derivative":{"exercise_price":13.41,"expiration_date":"2029-03-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-021281","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919119021281/doc4.xml","form_type":"4"}},{"id":3626565,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-28T18:26:02.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price is equal to the closing sales price per share of the Issuer's common stock as reported on The Nasdaq Global Market on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest as to 1/12 of the shares subject to the stock option on the one-month anniversary following February 26, 2019, and on the same calendar date of each successive month thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":5000,"derivative":{"exercise_price":7.23,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000904454-19-000274","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445419000274/edgar.xml","form_type":"4"}},{"id":3626564,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-28T18:26:02.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 26, 2019, subject to the Reporting Person's continued service with the Issuer through the vesting date.\n2. The exercise price is equal to the closing sales price per share of the Issuer's common stock as reported on The Nasdaq Global Market on the date of grant."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0000904454-19-000274","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445419000274/edgar.xml","form_type":"4"}},{"id":3646413,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-20T16:57:45.000Z","date":"2019-02-15","kind":"sale","acquired":false,"shares":3000,"price":7.14,"value":21420.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $7.09 to $7.20. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4."}],"balance_after":4500,"source":{"system":"sec-edgar","filing":"0000904454-19-000260","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445419000260/edgar.xml","form_type":"4"}},{"id":3707590,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-03T21:34:59.000Z","date":"2019-01-01","kind":"grant","acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of January 1, 2019, the Vesting Start Date."}],"balance_after":9375,"derivative":{"exercise_price":2,"expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001104659-19-000508","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465919000508/a4.xml","form_type":"4"}},{"id":3719303,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-26T16:05:29.000Z","date":"2018-12-21","kind":"sale","acquired":false,"shares":9330,"price":5.01,"value":46743.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $5.00 to $5.03. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1 to this Form 4."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0000904454-18-000798","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000798/edgar.xml","form_type":"4"}},{"id":3723237,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-20T20:29:25.000Z","date":"2018-12-20","kind":"purchase","acquired":true,"shares":5000,"price":9.98,"value":49900.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-18-063781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919118063781/doc4.xml","form_type":"4"}},{"id":3737433,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-10T16:05:15.000Z","date":"2018-12-06","kind":"purchase","acquired":true,"shares":5000,"price":11.26,"value":56300.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-18-061728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919118061728/doc4.xml","form_type":"4"}},{"id":3959155,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-20T20:05:22.000Z","date":"2018-04-18","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 12 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one-month anniversary of April 18, 2018, the Vesting Start Date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 12 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one-month anniversary of April 18, 2018, the Vesting Start Date."}],"balance_after":11250,"derivative":{"exercise_price":7.66,"expiration_date":"2028-04-17","underlying":"Common Stock, $0.001 par value per share","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001104659-18-025613","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465918025613/a4.xml","form_type":"4"}},{"id":3992184,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-16T20:23:06.000Z","date":"2018-03-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 12 months measured from March 14, 2018 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":10000,"derivative":{"exercise_price":9.5,"expiration_date":"2028-03-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-020453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919118020453/doc4.xml","form_type":"4"}},{"id":4052255,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-02-16T17:10:47.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price is equal to the closing sales price per share of the Issuer's common stock as reported on The Nasdaq Global Market on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option was granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, pursuant to the Paratek Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, effective January 1, 2018.  The stock option shall vest as to 1/12 of the shares subject to the stock option on the one-month anniversary following February 14, 2018, and on the same calendar date of each successive month thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date."}],"balance_after":5000,"derivative":{"exercise_price":14.15,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000904454-18-000195","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000195/edgar.xml","form_type":"4"}},{"id":4052254,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-16T17:10:47.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, pursuant to the Paratek Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, effective January 1, 2018.  Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 14, 2018, subject to the Reporting Person's continued service with the Issuer through the vesting date."}],"balance_after":16830,"source":{"system":"sec-edgar","filing":"0000904454-18-000195","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000195/edgar.xml","form_type":"4"}},{"id":4072270,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-07T17:57:41.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":2100,"price":14.22,"value":29862.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.43, inclusive. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":9330,"source":{"system":"sec-edgar","filing":"0000904454-18-000127","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445418000127/edgar.xml","form_type":"4"}},{"id":4352513,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-13T17:48:09.000Z","date":"2017-04-12","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 12 months measured from April 12, 2017 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":10000,"derivative":{"exercise_price":8.5,"expiration_date":"2027-04-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-026902","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919117026902/doc4.xml","form_type":"4"}},{"id":4466518,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-06T19:23:49.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price is equal to the closing sales price per share of Common Stock as reported on The Nasdaq Global Market on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares shall vest as to 1/12 of the shares on the one-month anniversary following February 2, 2017, and on the same calendar date of each successive month thereafter until fully vested, subject to the Reporting Person's continued service to the Company at each vesting date."}],"balance_after":6000,"derivative":{"exercise_price":15.1,"expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000904454-17-000107","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000107/edgar.xml","form_type":"4"}},{"id":4466517,"issuer":{"id":109529,"kind":"organization","name":"Paratek Pharmaceuticals, Inc.","symbol":"PRTK"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-06T19:23:49.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares shall vest on the one-year anniversary of February 2, 2017, subject to the Reporting Person's continued service to the Company at the vesting date"}],"balance_after":11430,"source":{"system":"sec-edgar","filing":"0000904454-17-000107","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178711/000090445417000107/edgar.xml","form_type":"4"}},{"id":4483945,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-23T23:15:04.000Z","date":"2017-01-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 12 equal quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of January 23, 2017, the Vesting Start Date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 12 equal quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of January 23, 2017, the Vesting Start Date."}],"balance_after":15000,"derivative":{"exercise_price":9.9,"expiration_date":"2027-01-22","underlying":"Common Stock, $0.001 par value per share","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-17-003614","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465917003614/a4.xml","form_type":"4"}},{"id":4483944,"issuer":{"id":6392,"kind":"organization","name":"CYPHERPUNK TECHNOLOGIES INC.","symbol":"CYPH"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-23T23:15:04.000Z","date":"2017-01-23","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted pursuant to Leap's Amended and Restated 2012 Equity Incentive Plan and is fully vested as of the grant date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The Option was granted pursuant to Leap's Amended and Restated 2012 Equity Incentive Plan and is fully vested as of the grant date."}],"balance_after":11000,"derivative":{"exercise_price":9.9,"expiration_date":"2027-01-22","underlying":"Common Stock, $0.001 par value per share","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-17-003614","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509745/000110465917003614/a4.xml","form_type":"4"}},{"id":4602484,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-15T14:41:45.000Z","date":"2016-03-28","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option grant was approved by Issuer's board of directors on March 28, 2016, subject to stockholder approval of an amendment of the Issuer's 2013 Equity Incentive Plan (the \"Plan\") under which the option was granted. Issuer's stockholders approved the amendment to the Plan on August 29, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in equal monthly installments over 24 months measured from March 28, 2016 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":23000,"derivative":{"exercise_price":15.75,"expiration_date":"2026-03-28","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-16-141542","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919116141542/doc4a.xml","form_type":"4/A","original_submission_date":"2016-04-01"}},{"id":4602483,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":19019,"kind":"person","name":"Dietz Thomas John","position":1,"cik":"0001574218","reported_name":"Dietz Thomas John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-15T14:41:45.000Z","date":"2016-03-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 12 months measured from March 28, 2016 subject to Reporting Person's continuous service status as of each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option grant was approved by Issuer's board of directors on March 28, 2016, subject to stockholder approval of an amendment of the Issuer's 2013 Equity Incentive Plan (the \"Plan\") under which the option was granted. Issuer's stockholders approved the amendment to the Plan on August 29, 2016."}],"balance_after":25000,"derivative":{"exercise_price":15.75,"expiration_date":"2026-03-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-16-141542","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919116141542/doc4a.xml","form_type":"4/A","original_submission_date":"2016-04-01"}}]}